Nuclear Sclerotic Cataract Clinical Trial
Official title:
Comparison of Scheimpflug Photos of the Crystalline Lens in Patients Who Have Undergone Vitrectony Surgery and Controls
| Verified date | July 2016 |
| Source | Barnes Retina Institute |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | United States: Institutional Review Board |
| Study type | Observational |
Progression of nuclear sclerotic cataract after pars plana vitrectomy has been recognized for many years The mechanism for the rapid progression of nuclear sclerotic cataract remains unclear. The objective of this trial is to evaluate and compare the level and progression of cataract advancement in controls versus eyes that have undergone 20-gauge pars plana vitrectomy and 25-gauge pars plana vitrectomy.
| Status | Completed |
| Enrollment | 49 |
| Est. completion date | October 2010 |
| Est. primary completion date | October 2010 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | Both |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - phakic eyes of patients that are scheduled to undergo pars plana vitrectomy, - controls will be phakic eyes of patients that have not undergone andy kind of intraocular surgery, - age 18 and older Exclusion Criteria: - any eye that is pseudophakic, - has had previous vitreoretinal surgery, - has had previous intravitreal injection, - previous intraocular inflammatory condition such as uveitis, - previous irradiation, - any patient with a history of ocular malignancy, - history of infectious intraocular condition |
Observational Model: Case-Only, Time Perspective: Prospective
| Country | Name | City | State |
|---|---|---|---|
| United States | Barnes Retina Institute | St. Louis | Missouri |
| Lead Sponsor | Collaborator |
|---|---|
| Barnes Retina Institute |
United States,